Terrence A. Duffy
At a glance: Terrence A. Duffy is CEO, Chair at CME Group (CME). Their latest SEC Form 4, filed Nov 19, 2026, reported a sale of $3.1M. On file: 0 purchase lines ($0) and 8 sale lines ($29.7M).
Disclosed holdings: about $11.0M of CME stock: 35,442 shares reported on their latest Form 4 (filed Nov 19, 2026), valued at the Nov 20, 2026 close of $311.15. This counts only CME shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CEO, Chair at Cme Group Inc. (CME)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Terrence A. Duffy's InsiderPrint
10 trades from SEC Form 4 filings, 2021 to 2026, drawn as one fingerprint.
Reading this print: Mostly sells, trading about 2 times a year, typically $3.2M a trade.
- Bump outward: a purchase (2)
- Dent inward: a sale (8)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Clark Jermoluk Founders Fund I LLC10% Owner · IBTA · 98% match
- John Ronald Jeffrey Jr.Director · AGX · 98% match
- Dominic NgCEO · EWBC · 98% match
- Ryan S. KeetonChief Brand Officer · CVNA · 98% match
- Ernest Scott SantiDirector · ITW · 97% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2021
From the SEC's insider data sets: each open-market buy by Terrence A. Duffy, matched to how the stock did over the next 90 days against the S&P 500.
1 of 1 buy beat the S&P 500 (100%), median +17.6% vs. the index. Small sample: treat with care. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| CME | Nov 8, 2021 | +17.6% |
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 19SEC | CMECme Group Inc. | Sell | 10,00052,442 held (−16%) | $308.54 | $3.1M | +0.8% |
| Nov 19SEC | CMECme Group Inc. | Sell | 17,00035,442 held (−32%) | $310.18 | $5.3M | +0.3% |
| Sep 11SEC | CMECme Group Inc. | Sell | 14,37241,258 held (−26%) | $274.41 | $3.9M | +13.4% |
| Sep 11SEC | CMECme Group Inc. | Sell | 62840,630 held (−2%) | $275.03 | $173K | +13.1% |
| May 18SEC | CMECme Group Inc. | Sell | 25,99664,634 held (−29%) | $298.14 | $7.8M | +4.4% |
| May 18SEC | CMECme Group Inc. | Sell | 9,00455,630 held (−14%) | $299.58 | $2.7M | +3.9% |
| Dec 15SEC | CMECme Group Inc. | Sell | 13,08977,715 held (−14%) | $269.10 | $3.5M | +15.6% |
| Dec 15SEC | CMECme Group Inc. | Sell | 11,91165,804 held (−15%) | $270.05 | $3.2M | +15.2% |
- Sell
CEO, Chair Terrence A Duffy sold $5.3M of CME at $310.18 — cuts the stake by 32%.
- Sell
CEO, Chair Terrence A Duffy sold $3.9M of CME at $274.41 — cuts the stake by 26%.
- Sell
CEO, Chair Terrence A Duffy sold $7.8M of CME at $298.14 — cuts the stake by 29%.
Follow Terrence A. Duffy
Get one email when Terrence A. Duffy files a new purchase or sale. Free.
At most one email a day about Terrence A. Duffy, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.